Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oxytocin Antagonist in Patients With Repeated Failure of Implantation. A Prospective Randomized Placebo-controlled Double-blind Study.

NCT01673399 is registered in ClinicalTrials.gov with AZ Jan Palfijn Gent as lead sponsor.

NCT NCT01673399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01673399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oxytocin Antagonist in Patients With Repeated Failure of Implantation. A Prospective Randomized Placebo-controlled Double-blind Study.
Lead sponsor
AZ Jan Palfijn Gent
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2012
Completion date
February 28, 2015
Enrollment
138 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

implantation failure